THC THERAPEUTICS, INC. Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- THC THERAPEUTICS, INC. payments for repurchase of common stock for the quarter ending 2023-07-31 was $0.00.
- THC THERAPEUTICS, INC. payments for repurchase of common stock for the quarter ending 2023-04-30 was $0.00, a 100.00% decline year-over-year.
- THC THERAPEUTICS, INC. payments for repurchase of common stock for the quarter ending 2022-07-31 was $0.00.
- THC THERAPEUTICS, INC. payments for repurchase of common stock for the quarter ending 2022-04-30 was $5.00K.
- THC THERAPEUTICS, INC. payments for repurchase of common stock for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- THC THERAPEUTICS, INC. payments for repurchase of common stock for fiscal 2022 was $97.50K.
- THC THERAPEUTICS, INC. payments for repurchase of common stock for fiscal 2021 was $0.00.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2023-07-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $0.00 10-K · filed 2024-02-26 |
| 2023-04-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-01-09 | |
| 2022-07-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $97.50K 10-K · filed 2024-02-26 |
| 2022-04-30 | $5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-01-09 | |
| 2021-07-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-25 | $0.00 10-K · filed 2022-11-25 |
| 2021-04-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-06-16 |